Hamilton Lane Advisors LLC Pulmonx Corp Transaction History

Hamilton Lane Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	BUY	$35.98 - $44.48 $681,641 - $842,673	18,945 Added 185.64%	29,150 $1.05 Million
Q2 2021 Jul 20, 2021	SELL	$37.61 - $48.0 $1.45 Million - $1.85 Million	-38,485 Reduced 79.04%	10,205 $450,000
Q1 2021 May 05, 2021	BUY	$44.0 - $67.54 $2.14 Million - $3.29 Million	48,690 New	48,690 $2.23 Million

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Hamilton Lane Advisors LLC with notifications on news.